| Trial ID: | L0499 |
| Source ID: | IRCT20100524004010N24
|
| Associated Drug: |
Curcumin
|
| Title: |
The effect of curcumin supplementation on lipid profile, liver enzymes, inflammatory factors and hepatic steatosis in patients with Nonalcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease. <br>Other specified inflammatory liver diseases;(K75.8)
|
| Interventions: |
Intervention 1: Intervention group: 1.5 gram curcumin per day for 3 months. Intervention 2: Control group: 1.5 gram maltodextrin per day for 3 months.
|
| Outcome Measures: |
Type of supplement. Timepoint: Begining and end of the study. Method of measurement: Data collection forms.;LDL-C. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;HDL-C. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;TG. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;Total Cholestrol. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;AST. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;ALT. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;TNF-a. Timepoint: Begining and end of the study. Method of measurement: ELISA.;Hs-CRP. Timepoint: Begining and end of the study. Method of measurement: ELISA.;Cytokeratin-18. Timepoint: Begining and end of the study. Method of measurement: ELISA.;IL-6. Timepoint: Begining and end of the study. Method of measurement: ELISA.;Hepatic Steatosis. Timepoint: Begining and end of the study. Method of measurement: Ultrasound.FBS. Timepoint: Begining and end of the study. Method of measurement: Enzymatic method using a kit.;Serum Insulin. Timepoint: Begining and end of the study. Method of measurement: Radioimmunoassay.;HOMA-IR. Timepoint: Begining and end of the study. Method of measurement: Calculation.;Ferritin. Timepoint: Begining and end of the study. Method of measurement: ELISA.;Uric Acid. Timepoint: Begining and end of the study. Method of measurement: ELISA.;Age. Timepoint: Begining of the study. Method of measurement: Question.;Sex. Timepoint: begining of the study. Method of measurement: observation.;Smoking. Timepoint: Begining of the study. Method of measurement: Questionare.;Height. Timepoint: Begining of the study. Method of measurement: Meter.;Weight. Timepoint: Begining and end of the study. Method of measurement: Balance.;BMI. Timepoint: Begining and end of the study. Method of measurement: Calculation.;Total Calorie Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total Carbohydrate Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total Protein Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total Fat Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total Fiber Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total MUFA Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total PUFA Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.;Total SFA Intake. Timepoint: Begining and end of the study. Method of measurement: Recall Questionare.
|
| Sponsor/Collaborators: |
Shahid Beheshti University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 yearsno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients will be randomly assigned to receive curcumin or placebo, Blinding description: The method use in this stud
|
| Start Date: |
14/05/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
18 June 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/4198
|
